Display options
Cite
Concha JSS, Afarideh M, Werth VP. Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis. Br J Dermatol. 2021;doi: 10.1111/bjd.20938.
Concha, J. S. S., Afarideh, M., & Werth, V. P. (2021). Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis. The British journal of dermatology, . https://doi.org/10.1111/bjd.20938
Concha, J S S, et al. "Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20938
Concha JSS, Afarideh M, Werth VP. Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis. Br J Dermatol. 2021 Dec 27; doi: 10.1111/bjd.20938. Epub 2021 Dec 27. PMID: 34961919.
Copy Download .nbib Format: NLM
Share it on

Br J Dermatol. 2021 Dec 27; doi: 10.1111/bjd.20938. Epub 2021 Dec 27.

Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis.

The British journal of dermatology

J S S Concha, M Afarideh, V P Werth

Affiliations

  1. Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA.
  2. Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

PMID: 34961919 DOI: 10.1111/bjd.20938

[No abstract available.]

References

  1. Isedeh P, Kohli I, Al-Jamal M et al. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol 2016; 174:862-8. - PubMed
  2. Bae-Harboe Y-SC, Graber EM. Easy as PIE (postinflammatory erythema). J Clin Aesthet Dermatol 2013; 6:46. - PubMed
  3. Brohem CA, da Silva Cardeal LB, Tiago M et al. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res 2011; 24:35-50. - PubMed
  4. Duval C, Chagnoleau C, Pouradier F et al. Human skin model containing melanocytes: essential role of keratinocyte growth factor for constitutive pigmentation - functional response to α-melanocyte stimulating hormone and forskolin. Tissue Eng Part C Methods 2012; 18:947-57. - PubMed
  5. Okazaki M, Suzuki Y, Yoshimura K et al. Construction of pigmented skin equivalent and its application to the study of congenital disorders of pigmentation. Scand J Plast Reconstr Surg Hand Surg 2005; 39:339-43. - PubMed
  6. Vellaichamy G, Kohli I, Zubair R et al. An in vivo model of postinflammatory hyperpigmentation and erythema: clinical, colorimetric and molecular characteristics. Br J Dermatol 2022; https://doi.org/10.1111/bjd.20804 - PubMed
  7. Hu R, O’Connell RM. MiR-23b is a safeguard against autoimmunity. Nat Med 2012; 18:1009-10. - PubMed
  8. Xu N, Meisgen F, Butler LM et al. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol 2013; 190:678-88. - PubMed
  9. Zhu S, Pan W, Song X et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med 2012; 18:1077-86. - PubMed
  10. Solé C, Domingo S, Ferrer B et al. MicroRNA expression profiling identifies miR-31 and miR-485-3p as regulators in the pathogenesis of discoid cutaneous lupus. J Invest Dermatol 2019; 139:51-61. - PubMed

Publication Types